1.4
Do you feel that metabolic saturation of the parent 1,4-DX compound is a molecular initiating event (MIE) in any of the MOAs listed above?
Results
(6 Answers)
Answer Explanations
- YesExpert 5Although widely accepted in our discipline, I remain uncomfortable with the term MIE. I view this as the first key event in the MOA. There is an assumption that the "MIE" is the most important determinant and if this step is identified it is the mechanism of the observed carcinogenciity. This approach does not take into account the mutistage, multistep process of the carcinogenesis process. Each of the Key events that follow this first key event exhibit dose response characteristics. Therefore while the first key event - "MIE" - starts the process subsequent key events need to be triggered for the eventual formation of the tumors. Given my bias on the terminaology, I concur that the evidence points to the metabolic saturation as the first key event.
- YesExpert 6The evidence for the role of the parent compound in cytotoxicity, and for the key role of cell death and regenerative proliferation in cancer development by 1,4-DX strongly indicate that metabolic saturation allowing the occurrence of substantial amounts of the parent compound is in fact a molecular initiating event in the MOA.
- NoExpert 4By convention, as above, the molecular initiating event is best described as cyp 2E1 induction. If possible, studies in cyp2E1 deficient or null animals would be extremely helpful in examining the essentiality of this key event for 1.4-DX. This would lend additional support to its hypothesized relevance as the critically important, limiting key event in the hypothesized MOA. As above, refinement of the PBK models, if possible, to address EPA concerns would also be helpful.
- YesExpert 2The initiation of oxidative stress and subsequent genomic damage that would produce hepatic growth arrest is likely an early event in the oncogenic process.
- NoExpert 1Metabolic saturation in my mind leads to MIE but is not a MIE itself.
- YesExpert 3See previous comment.
Expert 2
05/13/2024 12:25Expert 4
05/15/2024 09:34Expert 6
05/21/2024 10:19Expert 3
05/23/2024 16:48Expert 1
06/05/2024 15:51I agree with expert 4, MIE have been defined as part of the AOP process for toxicology outcomes. The AOP for Dioxane includes this and the citation below support this hypothesis. Again, ROS is produced (Totsuka et al., 2020) at high dose associated with metabolic saturation. ROS based MOA is a threshold based MOA (AOP 296) and will enable a risk assessment based BMD and a POD to generate human equivalent concentrations and assess margin of exposures.
Totsuka Y, Maesako Y, Ono H, Nagai M, Kato M, Gi M, Wanibuchi H, Fukushima S, Shiizaki K, Nakagama H. Comprehensive analysis of DNA adducts (DNA adductome analysis) in the liver of rats treated with 1,4-dioxane. Proc Jpn Acad Ser B Phys Biol Sci. 2020;96(5):180-187. doi: 10.2183/pjab.96.015. PMID: 32389918; PMCID: PMC7248212.